These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1712207)

  • 1. Lewy bodies in parkinsonism share components with intraneuronal protein bodies of normal brains.
    Issidorides MR; Mytilineou C; Panayotacopoulou MT; Yahr MD
    J Neural Transm Park Dis Dement Sect; 1991; 3(1):49-61. PubMed ID: 1712207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brain.
    Issidorides MR; Mytilineou C; Whetsell WO; Yahr MD
    Arch Neurol; 1978 Oct; 35(10):633-7. PubMed ID: 697603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of phospholipids in human catecholamine neurons with Baker's acid haematein.
    Panayotacopoulou MT; Boukis D; Issidorides MR
    J Neurocytol; 1989 Oct; 18(5):593-7. PubMed ID: 2482342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromelanin and Parkinson's disease.
    Marsden CD
    J Neural Transm Suppl; 1983; 19():121-41. PubMed ID: 6321645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine-rich proteins in spherical inclusions of human locus coeruleus neurons demonstrated by benzil modification.
    Panayotacopoulou MT; Issidorides MR
    J Histochem Cytochem; 1984 Nov; 32(11):1192-6. PubMed ID: 6208239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenaline storage function of species-specific protein bodies, markers of monoamine neurons in human locus coeruleus demonstrated by dopamine-beta-hydroxylase immunogold localization.
    Issidorides MR; Havaki S; Arvanitis DL; Chrysanthou-Piterou M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):829-47. PubMed ID: 15363607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine structure of neuronal spherical arginine-rich bodies of substantia nigra and locus coeruleus in the human brain.
    Issidorides MR; Pappas GD
    Hum Neurobiol; 1988; 6(4):239-46. PubMed ID: 2832354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease.
    Hirsch E; Ruberg M; Dardenne M; Portier MM; Javoy-Agid F; Bach JF; Agid Y
    Brain Res; 1985 Oct; 345(2):374-8. PubMed ID: 2994847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments.
    Forno LS; Sternberger LA; Sternberger NH; Strefling AM; Swanson K; Eng LF
    Neurosci Lett; 1986 Mar; 64(3):253-8. PubMed ID: 2421208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lewy body in Parkinson's disease.
    Forno LS
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarities between neuronal Lewy bodies in parkinsonism and hepatic Mallory bodies in alcoholism.
    Issidorides MR; Panayotacopoulou MT; Tiniacos G
    Pathol Res Pract; 1990 Aug; 186(4):473-8. PubMed ID: 2247376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructure of Lewy bodies in the stellate ganglion.
    Forno LS; Norville RL
    Acta Neuropathol; 1976 Mar; 34(3):183-97. PubMed ID: 178142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei.
    Braak E; Sandmann-Keil D; Rüb U; Gai WP; de Vos RA; Steur EN; Arai K; Braak H
    Acta Neuropathol; 2001 Mar; 101(3):195-201. PubMed ID: 11307617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
    Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
    Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural identification of protein bodies, cellular markers of human catecholamine neurons, in a temporal lobe ganglioglioma.
    Issidorides MR; Havaki S; Chrysanthou-Piterou M; Arvanitis DL
    Ultrastruct Pathol; 2000; 24(6):399-405. PubMed ID: 11206337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two antigens in parkinsonian Lewy bodies.
    Hirsch E; Ruberg M; Portier MM; Dardenne M; Agid Y
    Brain Res; 1988 Feb; 441(1-2):139-44. PubMed ID: 3359227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two cases.
    Mark MH; Sage JI; Dickson DW; Schwarz KO; Duvoisin RC
    Neurology; 1992 Jul; 42(7):1323-7. PubMed ID: 1620341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ; Kawamata H; Hyman BT
    Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy-body formation is an aggresome-related process: a hypothesis.
    Olanow CW; Perl DP; DeMartino GN; McNaught KS
    Lancet Neurol; 2004 Aug; 3(8):496-503. PubMed ID: 15261611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.